Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38166779)

  • 1. The current status of clinical trials on cancer and age disparities among the most common cancer trial participants.
    Zhao S; Miao M; Wang Q; Zhao H; Yang H; Wang X
    BMC Cancer; 2024 Jan; 24(1):30. PubMed ID: 38166779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated With Age Disparities Among Cancer Clinical Trial Participants.
    Ludmir EB; Mainwaring W; Lin TA; Miller AB; Jethanandani A; Espinoza AF; Mandel JJ; Lin SH; Smith BD; Smith GL; VanderWalde NA; Minsky BD; Koong AC; Stinchcombe TE; Jagsi R; Gomez DR; Thomas CR; Fuller CD
    JAMA Oncol; 2019 Dec; 5(12):1769-1773. PubMed ID: 31158272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.
    Javier-DesLoges J; Nelson TJ; Murphy JD; McKay RR; Pan E; Parsons JK; Kane CJ; Kader AK; Derweesh IH; Nodora J; Patel SP; Martinez ME; Rose BS
    Cancer; 2022 Feb; 128(4):770-777. PubMed ID: 34806168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
    Murthy VH; Krumholz HM; Gross CP
    JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
    Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
    J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of Patients in Ongoing Clinical Trials on Lung Cancer.
    Schulkes KJ; Nguyen C; van den Bos F; van Elden LJ; Hamaker ME
    Lung; 2016 Dec; 194(6):967-974. PubMed ID: 27650509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Older cancer patients in cancer clinical trials are underrepresented. Systematic literature review of almost 5000 meta- and pooled analyses of phase III randomized trials of survival from breast, prostate and lung cancer.
    Dunn C; Wilson A; Sitas F
    Cancer Epidemiol; 2017 Dec; 51():113-117. PubMed ID: 29126091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.
    Pang HH; Wang X; Stinchcombe TE; Wong ML; Cheng P; Ganti AK; Sargent DJ; Zhang Y; Hu C; Mandrekar SJ; Redman MW; Manola JB; Schilsky RL; Cohen HJ; Bradley JD; Adjei AA; Gandara D; Ramalingam SS; Vokes EE
    J Clin Oncol; 2016 Nov; 34(33):3992-3999. PubMed ID: 27646951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in the Inclusion of Racial and Ethnic Minority Groups and Older Adults in Prostate Cancer Clinical Trials: A Meta-analysis.
    Riaz IB; Islam M; Ikram W; Naqvi SAA; Maqsood H; Saleem Y; Riaz A; Ravi P; Wang Z; Hussain SA; Warner JL; Odedina FT; Duma N; Singh P; Kehl KL; Kamran SC; Murad MH; Landman A; Van Allen E; Bryce AH
    JAMA Oncol; 2023 Feb; 9(2):180-187. PubMed ID: 36416812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.
    Nilssen Y; Brustugun OT; Eriksen MT; Haug ES; Naume B; Møller B
    BMC Cancer; 2020 May; 20(1):488. PubMed ID: 32473650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of prior cancer on non-small cell lung cancer trial eligibility.
    Herman M; Liu Z; Shepherd FA; Leighl N; Liu G; Bradbury PA
    Cancer Med; 2021 Jul; 10(14):4814-4822. PubMed ID: 34145985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers.
    Cheng E; Soulos PR; Irwin ML; Cespedes Feliciano EM; Presley CJ; Fuchs CS; Meyerhardt JA; Gross CP
    JAMA Netw Open; 2021 Dec; 4(12):e2139593. PubMed ID: 34919133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in Breast, Lung, and Cervical Cancer Trials Worldwide.
    Ramaswami R; Paulino E; Barrichello A; Nogueira-Rodrigues A; Bukowski A; St Louis J; Goss PE
    J Glob Oncol; 2018 Sep; 4():1-11. PubMed ID: 30241268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer trial enrollment after state-mandated reimbursement.
    Gross CP; Murthy V; Li Y; Kaluzny AD; Krumholz HM
    J Natl Cancer Inst; 2004 Jul; 96(14):1063-9. PubMed ID: 15265967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in phase 1 cancer clinical trial enrollment.
    Perni S; Moy B; Nipp RD
    Cancer; 2021 Dec; 127(23):4464-4469. PubMed ID: 34379799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of socioeconomic status and race on trial participation for older women with breast cancer.
    Gross CP; Filardo G; Mayne ST; Krumholz HM
    Cancer; 2005 Feb; 103(3):483-91. PubMed ID: 15597407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of Patients From Racial and Ethnic Minority Groups in Phase 1 Early Cancer Drug Development Trials in the US, 2000-2018.
    Dunlop H; Fitzpatrick E; Kurti K; Deeb S; Gillespie EF; Dover L; Yerramilli D; Gomez SL; Chino F; Tsai CJ
    JAMA Netw Open; 2022 Nov; 5(11):e2239884. PubMed ID: 36326764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort.
    Lacey JV; Kreimer AR; Buys SS; Marcus PM; Chang SC; Leitzmann MF; Hoover RN; Prorok PC; Berg CD; Hartge P;
    BMC Cancer; 2009 Mar; 9():84. PubMed ID: 19292893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.